Acquisition Synergy Tempus AI acquired Arterys, integrating AI-powered imaging tools into a broader platform. This presents a cross-sell opportunity to offer bundled AI radiology capabilities and leverage Tempus’ enterprise relationships to accelerate adoption.

Cardio AI Growth Arterys has a robust Cardio AI suite with multiple FDA clearances and ongoing module expansions. Market to hospitals expanding cardiac imaging workflows seeking quantitative, workflow-integrated AI solutions to improve accuracy and efficiency.

Imaging Data Platform With 8 FDA clearances and leadership in cloud-based AI for medical imaging, target health systems prioritizing cloud-native, scalable AI that can unify diverse imaging modalities across sites and reduce radiologist workloads.

Global Reach & Partnerships Active in 118 countries and historically expanding via partnerships (example with Therapixel), pursue collaborations with distributors, imaging software vendors, and AI integrators to accelerate deployment in new regions and specialties.

Financial & Scale Upcoming or ongoing expansion opportunities may be tied to revenue growth through upsell of AI modules, cloud-based licensing, and enterprise deployments within Tempus’ platform, targeting mid-market to large health systems seeking comprehensive AI imaging solutions.